News & Events April

CTI Clinical Trial and Consulting Services President and CEO, Timothy J. Schroeder, to Present at Oracle’s 8th Annual Health Sciences Innovation Forum

April 15, 2013

Timothy J. Schroeder, President and CEO of CTI Clinical Trial and Consulting Services (CTI) will present at Oracle’s 8th Annual Health Sciences Innovation Forum, taking place April 18, 2013 in Parsippany, New Jersey. The forum will explore and discuss the evolving requirements of the health sciences industry.Mr. Schroeder will present ...

Read More

Galectin Therapeutics provides details on first-in-man Phase 1 clinical trial of GR-MD-02

April 10, 2013

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD 02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis. ...

Read More

April Newsletter - Role of Clinical Trials in Gene Therapy

April 1, 2013

Read More

Join Our Mailing List